Yuki Arita, M.D.,Ph.D
Yuki Arita, M.D.,Ph.D
Keio University School of Medicine
Verified email at - Homepage
Cited by
Cited by
Progressive site-directed therapy for castration-resistant prostate cancer: localization of the progressive site as a prognostic factor
S Yoshida, T Takahara, Y Arita, C Ishii, Y Uchida, K Nakagawa, K Toda, ...
International Journal of Radiation Oncology* Biology* Physics 105 (2), 376-381, 2019
Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including …
Y Arita, K Shigeta, H Akita, T Suzuki, R Kufukihara, TC Kwee, R Ishii, ...
European radiology 31, 875-883, 2021
Quantitative assessment of bone metastasis in prostate cancer using synthetic magnetic resonance imaging
Y Arita, T Takahara, S Yoshida, TC Kwee, S Yajima, C Ishii, R Ishii, ...
Investigative radiology 54 (10), 638-644, 2019
Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression
S Yajima, S Yoshida, T Takahara, Y Arita, H Tanaka, Y Waseda, ...
European radiology 29, 3881-3888, 2019
METastasis reporting and data system for prostate cancer as a prognostic imaging marker in castration-resistant prostate cancer
S Yoshida, T Takahara, C Ishii, Y Arita, Y Waseda, T Kijima, M Yokoyama, ...
Clinical Genitourinary Cancer 18 (4), e391-e396, 2020
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, ...
Urologic Oncology: Seminars and Original Investigations 40 (3), 105. e19-105 …, 2022
Deep learning algorithm for fully automated detection of small (≤ 4 cm) renal cell carcinoma in contrast-enhanced computed tomography using a multicenter database
N Toda, M Hashimoto, Y Arita, H Haque, H Akita, T Akashi, H Gobara, ...
Investigative radiology 57 (5), 327-333, 2022
Whole‐body diffusion‐weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond
S Yoshida, T Takahara, Y Arita, S Sakaino, K Katahira, Y Fujii
International Journal of Urology 28 (5), 502-513, 2021
Diagnostic value of computed high b-value whole‐body diffusion-weighted imaging for primary prostate cancer
Y Arita, S Yoshida, Y Waseda, T Takahara, C Ishii, R Ueda, TC Kwee, ...
European Journal of Radiology 137, 109581, 2021
Utility of radiomics features of diffusion-weighted magnetic resonance imaging for differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma: model …
S Matsumoto, Y Arita, S Yoshida, H Fukushima, K Kimura, I Yamada, ...
Abdominal Radiology 47 (6), 2178-2186, 2022
Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic …
R Kufukihara, E Kikuchi, K Shigeta, K Ogihara, Y Arita, H Akita, T Suzuki, ...
Urologic Oncology: Seminars and Original Investigations 40 (2), 61. e1-61. e8, 2022
Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration‐Resistant Prostate Cancer
S Yamamoto, S Yoshida, C Ishii, T Takahara, Y Arita, H Fukushima, ...
Journal of Magnetic Resonance Imaging 54 (2), 401-408, 2021
Diagnostic value of texture analysis of apparent diffusion coefficient maps for differentiating fat-poor angiomyolipoma from non-clear-cell renal cell carcinoma
Y Arita, S Yoshida, TC Kwee, H Akita, S Okuda, Y Iwaita, K Mukai, ...
European Journal of Radiology 143, 109895, 2021
The efficacy of the TachoSil binding suturing technique in laparoscopic partial nephrectomy to prevent the development of pseudoaneurysm
K Shigeta, K Matsumoto, T Abe, A Komatsuda, T Takeda, R Mizuno, ...
Asian Journal of Surgery 43 (6), 668-675, 2020
Diagnostic value of the vesical imaging-reporting and data system in bladder urothelial carcinoma with variant histology
Y Arita, S Yoshida, K Shigeta, TC Kwee, H Edo, N Okawara, M Hashimoto, ...
European urology oncology 6 (1), 99-102, 2023
Apparent diffusion coefficient map-based texture analysis for the differentiation of chromophobe renal cell carcinoma from renal oncocytoma
Y Uchida, S Yoshida, Y Arita, H Shimoda, K Kimura, I Yamada, H Tanaka, ...
Diagnostics 12 (4), 817, 2022
Impact of progressive site-directed therapy in oligometastatic castration-resistant prostate cancer on subsequent treatment response
S Yoshida, T Takahara, Y Arita, K Toda, K Kimura, H Tanaka, ...
Cancers 14 (3), 567, 2022
Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry …
Y Arita, H Akita, H Fujiwara, M Hashimoto, K Shigeta, TC Kwee, ...
European Journal of Radiology Open 9, 100403, 2022
Genuine-and induced-oligometastatic castration-resistant prostate cancer: clinical features and clinical outcomes after progressive site-directed therapy
S Yoshida, T Takahara, Y Arita, K Toda, I Yamada, H Tanaka, ...
International Urology and Nephrology 53, 1119-1125, 2021
Patterns of failure after progressive site‐directed therapy in oligo‐progressive castration‐resistant prostate cancer
S Yoshida, T Takahara, Y Arita, K Toda, R Yoshimura, Y Fujii
International Journal of Urology 27 (7), 634-635, 2020
The system can't perform the operation now. Try again later.
Articles 1–20